*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Drug Utilization Evaluation of Higher End Antibiotics inan Intensive Medical Care Unit ofa Tertiary Care Hospital

Author: JENI SHARON, BONISH ROMANCE, LAKSHMI S, JASNOSAJI JOHN, BABUN, AARTHIPRAKASAM, S.RAMALAKSHMI
Abstract: Intensive care unit (ICU) requires emergent coverage with empirical broad-spectrum antibiotics, with a subsequentde-escalation based on culture report. Antimicrobial resistance has emerged as an important determinant of outcome for patients in the intensive care unit. Hence, the present study was aimed to evaluate the prescriptions with higher end antibiotics among critically ill patients. This was aprospective cross sectional observational study conducted in the Intensive Medical Care Unit of a tertiary care hospital in Chennai for a period of 6months. The data of patients prescribed with the selected higher end was collected using a pre-structured data entry form. Theantibiotics prescribed were analysed for appropriateness based on several criteria with the Hospital antibiotic policy.A total of 271 high end antibiotics were prescribed for 160 patients of which PiperacillinTazobactam (33.5%) and Meropenem (30.6%) were predominant. About 70.11% were on empiric therapy and 29.8% were on definitive therapy based on culture test. The most prevailing organism was found to beEscherichiacoli(35.8%). There was an increase in resistance to PiperacillinTazobactamtowardsEscherichiacoli (39.4%), Klebsiella pneumonia (55%) and Acinetobacterbaumannii(71.4%). Prescription analyses indicate, 18.45 % of inappropriateness. The main reason for inappropriateness was with respect to dosage adjustment (11 %), dosing interval (9.22 %) anddose (7.38%).There was a satisfactory standard has maintained inthe hospital. However, dosing adjustment in renalpatient need further intervention to improve the quality of health care
Keyword: Drug Utilisation Evaluation, Antimicrobial Resistance, Restricted Antibiotic
DOI: https://doi.org/10.31838/ijpr/2019.11.03.022
Download: Request For Article
 
Clients

Clients

Clients

Clients

Clients
ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free